Equity Analysis /
United States of America

US : UnitedHealth Group Incorporated - UNH | OptumCare Remains Highlight With Significant Room For Growth; Reiterate SB1 and $405 PT

    Alex Ruscher
    Alex Ruscher

    Sr. Res. Assoc.

    20 January 2021
    Published byCGS-CIMB

    We reiterate our Strong Buy rating and $405 price target on shares of UNH following 4Q20 results that came in ahead of expectations while management maintained its wide ranged 2021 adj. EPS guidance of $17.75-18.25. The 2021 outlook includes ~$1.80/share of COVID headwinds or $2B of operating incom